These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 16464782)

  • 1. Serum matrix metalloproteinase-9 and venous bypass graft occlusion.
    Kalela A; Limnell V; Aittoniemi J; Virtanen V; Jaakkola O; Lehtimäki T; Nikkari ST
    Scand J Clin Lab Invest; 2006; 66(1):7-14. PubMed ID: 16464782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRP, IL-6 and endothelin-1 levels in patients undergoing coronary artery bypass grafting. Do preoperative inflammatory parameters predict early graft occlusion and late cardiovascular events?
    Hedman A; Larsson PT; Alam M; Wallen NH; Nordlander R; Samad BA
    Int J Cardiol; 2007 Aug; 120(1):108-14. PubMed ID: 17141340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Higher platelet activity is present in patients with restenosis after percutaneous coronary intervention compared with patients with an occlusion of coronary artery bypass graft.
    Osmancik PP; Bednar F; Pavkova L; Tousek P; Stros P; Jirasek K
    Blood Coagul Fibrinolysis; 2008 Dec; 19(8):807-12. PubMed ID: 19002048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Factors determining late patency of aortobifemoral bypass graft].
    Davidović LB; Lotina SI; Kostić DM; Cinara II; Cvetković SD; Stojanov PL; Velimirović DB; Marković MM; Pejkić SA; Vukotić AM
    Srp Arh Celok Lek; 1997; 125(1-2):24-35. PubMed ID: 17974352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A differential release of matrix metalloproteinases 9 and 2 during coronary artery bypass grafting and off-pump coronary artery bypass surgery.
    Sokal A; Zembala M; Radomski A; Kocher A; Pacholewicz J; Los J; Jedrzejczyk E; Zembala M; Radomski M
    J Thorac Cardiovasc Surg; 2009 May; 137(5):1218-24. PubMed ID: 19379995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of coronary bypass grafting in a population of middle-aged men.
    Dudas KA; Wilhelmsen L; Rosengren A
    Eur J Cardiovasc Prev Rehabil; 2007 Feb; 14(1):122-7. PubMed ID: 17301637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of patient and target-vessel characteristics on arterial and venous bypass graft patency: insight from a randomized trial.
    Desai ND; Naylor CD; Kiss A; Cohen EA; Feder-Elituv R; Miwa S; Radhakrishnan S; Dubbin J; Schwartz L; Fremes SE;
    Circulation; 2007 Feb; 115(6):684-91. PubMed ID: 17283268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pathohistologic changes in aortocoronary venous grafts].
    Vucković D; Vucković N
    Med Pregl; 1995; 48(9-10):305-9. PubMed ID: 8628184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative statin therapy is associated with reduced cardiac mortality after coronary artery bypass graft surgery.
    Collard CD; Body SC; Shernan SK; Wang S; Mangano DT; ;
    J Thorac Cardiovasc Surg; 2006 Aug; 132(2):392-400. PubMed ID: 16872968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of preoperative renal dysfunction on one-year bypass graft patency and two-year outcomes in patients undergoing coronary artery bypass surgery.
    Mehta RH; Hafley GE; Gibson CM; Harrington RA; Peterson ED; Mack MJ; Kouchoukos NT; Califf RM; Ferguson TB; Alexander JH;
    J Thorac Cardiovasc Surg; 2008 Nov; 136(5):1149-55. PubMed ID: 19026795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal timing of coronary artery bypass after acute myocardial infarction: a review of California discharge data.
    Weiss ES; Chang DD; Joyce DL; Nwakanma LU; Yuh DD
    J Thorac Cardiovasc Surg; 2008 Mar; 135(3):503-11, 511.e1-3. PubMed ID: 18329460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myocardial infarction following coronary artery bypass graft surgery increases healthcare resource utilization.
    Chen JC; Kaul P; Levy JH; Haverich A; Menasché P; Smith PK; Carrier M; Verrier ED; Van de Werf F; Burge R; Finnegan P; Mark DB; Shernan SK;
    Crit Care Med; 2007 May; 35(5):1296-301. PubMed ID: 17414091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic total occlusion treatment in post-CABG patients: saphenous vein graft versus native vessel recanalization-long-term follow-up in the drug-eluting stent era.
    Meliga E; García-García HM; Kukreja N; Daemen J; Tanimoto S; Ramcharitar S; van Mieghem CA; Sianos G; van der Ent M; van der Giessen WJ; de Feyter P; van Domburg R; Serruys PW
    Catheter Cardiovasc Interv; 2007 Jul; 70(1):21-5. PubMed ID: 17584913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Baseline serum matrix metalloproteinase-9 level predicts long-term prognosis after coronary revascularizations in stable coronary artery disease.
    Ye ZX; Leu HB; Wu TC; Lin SJ; Chen JW
    Clin Biochem; 2008 Mar; 41(4-5):292-8. PubMed ID: 18067861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myocardial enzyme release in totally endoscopic coronary artery bypass grafting on the arrested heart.
    Schachner T; Bonaros N; Ruetzler E; Weidinger F; Oehlinger A; Laufer G; Friedrich G; Bonatti J
    J Thorac Cardiovasc Surg; 2007 Oct; 134(4):1006-11. PubMed ID: 17903521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of lipoprotein(a) excess with early vein graft occlusions in middle-aged men undergoing coronary artery bypass surgery.
    Pokrovsky SN; Ezhov MV; Il'ina LN; Afanasieva OI; Sinitsyn VY; Shiriaev AA; Akchurin RS
    J Thorac Cardiovasc Surg; 2003 Oct; 126(4):1071-5. PubMed ID: 14566249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of saphenous vein graft versus right gastroepiploic artery to revascularize the right coronary artery: a prospective randomized clinical, functional, and angiographic midterm evaluation.
    Glineur D; Hanet C; Poncelet A; D'hoore W; Funken JC; Rubay J; Astarci P; Lacroix V; Verhelst R; Etienne PY; Noirhomme P; El Khoury G
    J Thorac Cardiovasc Surg; 2008 Aug; 136(2):482-8. PubMed ID: 18692661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matrix metalloproteinase circulating levels, genetic polymorphisms, and susceptibility to acute myocardial infarction among patients with coronary artery disease.
    Hlatky MA; Ashley E; Quertermous T; Boothroyd DB; Ridker P; Southwick A; Myers RM; Iribarren C; Fortmann SP; Go AS;
    Am Heart J; 2007 Dec; 154(6):1043-51. PubMed ID: 18035073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pexelizumab reduces death and myocardial infarction in higher risk cardiac surgical patients.
    Haverich A; Shernan SK; Levy JH; Chen JC; Carrier M; Taylor KM; Van de Werf F; Newman MF; Adams PX; Todaro TG; van der Laan M; Verrier ED
    Ann Thorac Surg; 2006 Aug; 82(2):486-92. PubMed ID: 16863750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double supply to left anterior descending artery by additional saphenous vein graft in internal thoracic artery malperfusion syndrome.
    Sismanoglu M; Bozbuga N; Ozkaynak B; Polat A; Erentug V; Akinci E; Ipek G; Balkanay M; Yakut C
    J Card Surg; 2006; 21(4):410-3. PubMed ID: 16846424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.